Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1710
-0.0241 (-12.34%)
At close: Jan 9, 2026
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $790.16 thousand as of January 9, 2026. Its market cap has decreased by -76.32% in one year.
Market Cap
790.16K
Enterprise Value
-801.53K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 790.16K, a decrease of -97.08%. That is a compound annual growth rate of -68.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 790.16K | -5.00% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Glass House Brands | 711.87M |
| Elite Pharmaceuticals | 521.08M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 260.73M |